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Motoneuron Death Triggered by a Specific
Pathway Downstream of Fas:
Potentiation by ALS-Linked SOD1 Mutations
death genes are involved in death of different cell types
and that a given cell may activate distinct death path-
ways when triggered to die by different stimuli (Pett-
mann and Henderson, 1998). One striking example of
the former concerns Bax, a Bcl-2 family member which
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We have addressed this general question in the spe-Summary
cific context of the death of motoneurons triggered by
activation of Fas, which has been recently implicated inDeath pathways restricted to specific neuronal
the developmental and lesion-induced death of neurons.classes could potentially allow for precise control of
Fas (APO-1/CD95) is a member of the death receptordevelopmental neuronal death and also underlie the
family that includes the tumor necrosis factor receptorselectivity of neuronal loss in neurodegenerative dis-
(TNFR) and the low-affinity neurotrophin receptor p75NTR.ease. We show that Fas-triggered death of normal
Upon engagement by its ligand FasL, the intracellularembryonic motoneurons requires transcriptional upreg-
death domain of Fas recruits the adaptor moleculeulation of neuronal NOS and involves Daxx, ASK1, and
FADD, leading to the activation of caspase 8 and subse-p38 together with the classical FADD/caspase-8 cas-
quent activation of a caspase cascade resulting in cellcade. No evidence for involvement of this pathway was
death (Kischkel et al., 1995; Nagata, 1997). The functionfound in cells other than motoneurons. Motoneurons
of Fas has been most studied in the immune system,from transgenic mice overexpressing ALS-linked SOD1
where activation of Fas leads to deletion of activatedmutants (G37R, G85R, or G93A) displayed increased
mature T cells at the end of an immune response andsusceptibility to activation of this pathway: they were
to killing of virus-infected cells or cancer cells by cyto-more sensitive to Fas- or NO-triggered cell death but
toxic T cells and natural killer cells (Krammer, 2000). Innot to trophic deprivation or excitotoxic stimulation.
the brain, a subset of cortical neurons express Fas inThus, triggering of a motoneuron-restricted cell death
close proximity to cells expressing FasL, and death canpathway by neighboring cells might contribute to mo-
be triggered in a proportion of these neurons in vitro bytoneuron loss in ALS.
Fas activation (Cheema et al., 1999). In models of brain
ischemia, expression of Fas and increased levels of ac-Introduction
tive caspase-8 have been reported (Herdegen et al.,
1998; Matsushita et al., 2000; Matsuyama et al., 1995;The remarkable degree of conservation of programmed
Northington et al., 2001), and there is a reduction ofcell death (PCD) pathways between different organisms
stroke-induced brain damage in the absence of FasLand cell types has led to the paradigmatic concept of
(Martin-Villalba et al., 1999). We recently showed thata “central cell death pathway” in which upstream events
cultured motoneurons deprived of trophic support ex-trigger activation of caspases, often through mecha-
press increased levels of FasL and can be kept alive bynisms involving control of cytochrome c release from
blocking extracellular Fas/FasL interactions, showingmitochondria (Green and Kroemer, 1998; Pettmann and
that Fas activation is a driving force for cell death inHenderson, 1998). However, it is clear that different cell
these conditions (Raoul et al., 1999). Moreover, even in
the presence of trophic factors, exogenous activation of
4 Correspondence: chris@ibdm.univ-mrs.fr the Fas system induces death of50% of motoneurons5 These authors contributed equally to this work.
through a pathway involving caspase-8 (Raoul et al.,6 Present address: Department of Anatomy and Neurobiology,
1999). This system provided a means for studying signal-Washington University Medical School, Campus Box 8108, 660
South Euclid Avenue, St. Louis, Missouri 63110. ing mechanisms that are downstream of Fas, indepen-
Neuron
1068
dently of other mechanisms involved in death induced deprivation, embryonic mouse E12.5 motoneurons were
cultured in the continuous presence of optimal concen-by trophic deprivation.
Amyotrophic lateral sclerosis (ALS) is a late-onset trations of neurotrophic factors (NTFs; see Experimental
Procedures) for 16 hr before addition of agonistic anti-neurodegenerative disease characterized by the selec-
tive degeneration and death of motoneurons in spinal Fas antibody or soluble Fas ligand (sFasL) (Raoul et al.,
1999). By RT-PCR analysis 24 hr later, none of the NOScord, brainstem, and cerebral cortex. While most ALS
cases appear spontaneously, about 10% are familial isoforms was detected in motoneurons cultured in the
presence of trophic factors alone. However, agonistic(FALS). Of these, 10%–20% (1%–2% of total) are linked
to various dominantly inherited mutations in the gene anti-Fas antibody strikingly increased the level of mRNA
for nNOS, without affecting the other isoforms (Figureencoding superoxide dismutase 1 (SOD1). FALS pathol-
ogy is mimicked to a striking degree in several lines 1A). Levels of nNOS protein detected by immunofluores-
cence also increased following Fas activation (Figureof transgenic mice for human ALS-linked SOD1 gene
mutations (reviewed in Cleveland and Rothstein, 2001). 1B): the fraction of intensely stained motoneurons in-
creased from 8.7%  1.7% to 24.7%  3.0% (mean However, the mechanism(s) by which SOD1 mutations
cause ALS are still unsolved. The nature of mutant SOD1 SD, n  3) at 24 hr after sFasL application (data not
shown, see also Figure 3D). Thus, Fas activation in moto-toxicity remains highly controversial (Beckman et al.,
2001; Cleveland and Rothstein, 2001; Julien, 2001; Shaw neurons leads to the transcription and translation of
nNOS.and Eggett, 2000). Moreover, the molecular pathways
leading to motoneuron degeneration have not been elu- We next asked whether functional nNOS was required
for Fas-induced death. Survival of motoneurons wascidated: it has been shown that mutant SOD1 can trigger
cell death in neuronal cell cultures (Ciriolo et al., 2000; assessed by direct cell counting 48 hr after treatment
with agonistic anti-Fas antibody in the presence of NTFs.Ghadge et al., 1997; Rabizadeh et al., 1995) and in moto-
neurons (Durham et al., 1997), but genetic, pharma- Fas-triggered death was completely blocked by the
wide-spectrum NOS inhibitor L-NAME (Table 1) and bycologic, and biochemical studies in ALS patients and
mutant SOD1 mice have given controversial results con- inhibitors specific for nNOS: NPLA (Zhang et al., 1997),
LVNIO (Babu and Griffith, 1998), or TRIM (Handy et al.,cerning the engagement of the classical apoptotic cas-
cade (Kostic et al., 1997; Li et al., 2000; Migheli et al., 1995) at 10 M (Figure 1C). Thus, production of NO by
nNOS is necessary for Fas to exert its killing effect in1999; Migheli et al., 1994; Pasinelli et al., 2000). Last,
the cellular site of action of the mutations remains enig- motoneurons.
matic, since motoneuron degeneration has only been
observed in transgenic mice when SOD1 mutants were Potential Involvement of Superoxide and
ubiquitously expressed under the control of their own Peroxynitrite in Fas-Triggered Cell Death
promoter but not after specific overexpression in neu- Nitric oxide reacts spontaneously with superoxide anion
rons (Lino et al., 2002; Pramatarova et al., 2001) or in to form peroxynitrite, which has been implicated in sev-
astrocytes (Gong et al., 2000). eral degenerative processes. We therefore tested for the
Results presented here provide a potential answer to potential involvement of superoxide and peroxynitrite in
some of these questions. We first show that death of Fas-mediated death. The superoxide and peroxynitrite
normal motoneurons triggered by Fas activation in- scavenger MnTBAP (Faulkner et al., 1994) rescued
volves transcriptional upregulation of neuronal nitric ox- about 75% of the motoneurons that normally die follow-
ide synthase (NOS). We could find no evidence for this ing Fas activation (Figure 1D). To test whether peroxyni-
pathway in other Fas-responsive cell types. We next trite was indeed produced after Fas activation, we as-
isolated embryonic motoneurons from transgenic mu- sayed for tyrosine nitration, a footprint left by the oxidant
tant SOD1 mice. These motoneurons displayed greatly (Reiter et al., 2000). Following labeling using an anti-
increased sensitivity to activation of Fas and its intracel- nitrotyrosine antibody, immunoreactivity of randomly
lular relay nitric oxide (NO) but not to trophic factor selected cells was quantified in a blinded manner using
deprivation or excitotoxicity. Thus, activation of a moto- confocal microscopy (Figure 1E). Fluorescence values
neuron-restricted signaling pathway may underlie selec- were grouped into three categories, corresponding to
tive loss of motoneurons in these models of ALS. low, medium, and high intensity. In the absence of Fas
activators, motoneurons showed only low fluorescence
intensity, whereas following Fas activation, nearly allResults
motoneurons were classified in the medium or high cate-
gories. L-NAME and MnTBAP each completely blockedNeuronal NOS Is Specifically Upregulated in
the effects of Fas activation. Thus, peroxynitrite is pro-Motoneurons Following Fas Activation and Its
duced downstream of nNOS during Fas-triggered moto-Activity Is Essential for Fas-Induced Death
neuron death.The observation that motoneuron death triggered by
exogenous activation of Fas takes at least 48 hr (Raoul
et al., 1999) raised the possibility that transcriptional p38 Kinase Controls nNOS Activation
during Fas-Induced Deathevents might be involved. As neuronal NOS (nNOS) has
been implicated in motoneuron death induced by tro- How is nNOS expression induced following Fas activa-
tion? Stress-activated protein kinases such as Jun N-ter-phic deprivation (Estevez et al., 1998b), we looked for
potential involvement of nNOS and two other NOS family minal kinases (JNK) and p38 kinase (p38) play major
roles in linking membrane receptors to the transcrip-members, inducible NOS (iNOS) and endothelial NOS
(eNOS), in Fas signaling. To avoid effects due to trophic tional machinery (Paul et al., 1997) and in apoptosis.
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Figure 1. Requirement for Nitric Oxide in
Fas-Triggered Death of Motoneurons
(A) Only the neuronal isoform of NOS is upreg-
ulated following Fas activation. Motoneurons
were cultured for 16 hr in the presence of
an optimal cocktail of neurotrophic factors
(referred to as “NTFs”: 1 ng/ml BDNF, 100 pg/
ml GDNF, 10 ng/ml CNTF) and were treated or
not with agonistic anti-Fas antibody (JO2, 100
ng/ml) for 24 hr. The expression of different
isoforms of NOS (n, neuronal; i, inducible; e,
endothelial) was assessed by RT-PCR (35 cy-
cles) followed by Southern blotting with spe-
cific internal probes. Concentrations of cDNA
were normalized using -actin (24 cycles) as
standard.
(B) Immunocytochemistry for nNOS on
mouse motoneurons following Fas activation.
Culture and treatment conditions as in (A).
Typical immunofluorescence for each condi-
tion is shown; cell counts are given in the text.
(C) Specific inhibitors of nNOS save motoneu-
rons from Fas-induced death. After 16 hr of
culture, increasing concentrations of the se-
lective nNOS inhibitors NPLA, LVNIO, or TRIM
were added at the same time as agonistic
anti-Fas antibody (100 ng/ml). Cell survival
was measured 48 hr later.
(D) The free radical scavenger MnTBAP pro-
tects motoneurons from Fas-triggered death.
Survival assays were performed as in (C).
When added alone, MnTBAP had no effect
on cell survival but was toxic above 50 M.
Values in (C) and (D) are means  SD of tripli-
cates, representative of three independent
experiments.
(E) Fas activation leads to nitrotyrosine for-
mation, a footprint of peroxynitrite produc-
tion. Motoneurons were cultured on cov-
erslips, fixed 24 hr after the indicated
treatments, and immunostained for nitrotyro-
sine. Immunofluorescence of randomly se-
lected cells was analyzed in a blinded fashion
(see Experimental Procedures). Values (arbi-
trary units) were classified into three catego-
ries: low (0–1000), medium (1000–2000), and
high (above 2000) intensity.
Furthermore, MAP kinases have been shown to be in- tions of inhibitor (Figure 2C), implicating p38 kinase in
Fas-induced death. In contrast, the JNK inhibitorvolved in the regulation of NOS expression (Da Silva et
al., 1997). We therefore investigated whether MAP ki- L-JNKI1 (Bonny et al., 2001) used at 1 M provided no
protection against Fas-induced death, although it didnase activation played a role in Fas-induced death.
We prepared extracts of motoneurons treated or not save50% of motoneurons from death induced by tro-
phic deprivation (data not shown).with sFasL and performed Western blot analysis using
specific antibodies to phosphorylated forms of p38 and We next investigated whether p38 was acting in the
novel pathway involving nNOS. Inhibiting p38 activityJNKs (46 and 54 kDa) (Figure 2A). By densitometric scan-
ning, we found a modest but reproducible increase by 5M SB203580 strongly inhibited nNOS upregulation
following Fas activation (Figure 2D). Moreover, exoge-(2.9  0.8-fold, mean  range, n  2) in relative levels
of phospho-p38 following Fas activation but no change nous NO (20 M) restored the Fas killing effect in the
presence of 5M SB203580 (data not shown). Thus, onein the levels of phospho-JNK (Figure 2B).
To confirm the functional significance of p38 activa- principal role of p38 in these conditions is to enhance NO
production.tion, we tested the ability of different doses of the inhibi-
tor SB203580 to inhibit Fas-triggered motoneuron
death. Low concentrations (5 M) of SB203580 block Fas-Mediated Death Requires Signaling
through Daxx-ASK1-p38p38 selectively, whereas higher concentrations (30 M)
block both p38 and JNK (Le-Niculescu et al., 1999). We next investigated Fas signaling upstream of p38.
One of the MAPK kinase kinases (MAP3K) that can con-Fas-induced death was blocked completely by 5 M
SB203580, and as many as 65% of Fas-sensitive moto- trol p38 activation is the apoptosis signal-regulating ki-
nase 1 (ASK1) (Tobiume et al., 2001). Since no specificneurons were saved even by 10-fold lower concentra-
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pension were briefly preincubated with the DNA to beTable 1. Pharmacologic Analysis of the Requirement for nNOS in
transfected and then electroporated using a square-Fas-Induced Death
wave generator before seeding in culture wells. Al-
Percent Surviving
though a large percentage of motoneurons were killedTreatment at 1 DIV MNs at 3 DIV SD
outright by the procedure, the remaining cells survived
NTFs 100 4.7 and developed well in culture, showing normal morphol-
anti-Fas 55 5.6
ogy, neurite outgrowth (Figure 3A) and responses to a
anti-Fas  L-NAME 96.3 5.5 range of known growth and survival factors as well as
L-NAME 100.7 6.5
to Fas agonists (data not shown). When an expressionanti-Fas  D-NAME 51 3
plasmid encoding EGFP under the control of a strongD-NAME 104 4.1
promoter (CMV) was electroporated, between 50% andanti-Fas  L-NAME  DETANONOate 54.2 3.7
70% of the surviving neurons became strongly fluores-L-NAME  DETANONOate 95 5
cent after less than 24 hr in culture. When two expressionanti-Fas  DETANONOate 54.2 5.7
anti-Fas  DETA 54.9 5 plasmids were transfected, the efficacy of coelectropor-
anti-Fas  DETA  L-NAME 98 3.8 ation was 95%  3% (mean  range, n  2; Figure 3A).
L-NAME  DETA 93 3.5 Thus, this technique should be of general interest for
DETANONOate 93 7.5
studying signaling mechanisms in neurons.DETA 96.3 9.2
We transfected motoneurons with plasmids coding
Motoneurons were treated with the indicated reagents (100 ng/ml anti- for EGFP in combination with plasmids coding for either
Fas antibody, 100 M L-NAME, 100 M D-NAME, 20 M DETAN-
wild-type ASK1 or a dominant-negative form of ASK1ONOate, 20 M of the DETA moiety, see Experimental Procedures).
in which a point mutation leads to a catalytically inactiveThe percentage of surviving motoneurons was estimated after 48 hr.
Values are means of three independent experiments  SD. enzyme (ASK1-K709R; [Saitoh et al., 1998]). Whereas
overexpression of wild-type ASK1 had no effect on Fas-
induced death, overexpression of ASK1-K709R pro-
vided complete protection (Figure 3B). These resultsinhibitors are available for ASK1, we needed to use a
make ASK1 an excellent candidate for the control ofdominant-negative approach. To overcome the relative
p38 activation in these conditions.refractoriness of motoneurons to standard transfection
Daxx is a Fas-associated protein that has been impli-methods, we developed a novel electroporation method
cated in Fas signaling in some cell types and can actfor transducing purified motoneurons. As described in
Experimental Procedures, purified motoneurons in sus- upstream of ASK1 (Chang et al., 1998). In order to deter-
Figure 2. Role of p38 in Fas-Induced Death
(A and B) Increase in phosphorylation of p38
kinase but not JNKs following Fas activation.
Motoneurons cultured with NTFs were
treated or not with sFasL for 2 hr. Phosphory-
lation of p38 kinase and the JNKs was ana-
lyzed on Western blots (A) using antibodies
against phosphorylated p38 kinase (p-p38,
42 kDa) and phosphorylated JNKs (p-JNKs,
46 and 54 kDa). Neurofilament (NF-M) immu-
noreactivity was used as a loading control.
Densitometric scanning (B) of Western blots
confirmed the specific increase in phosphor-
ylated p38 following Fas activation. Intensity
values were corrected for loading differences
(monitored through NF-M) and then ex-
pressed as the ratio of treated to untreated
values. Values are means  range, n  2.
(C) The p38 kinase inhibitor SB203580 saves
motoneurons from Fas-induced death. Moto-
neurons were incubated with increasing con-
centrations of SB203580 added together with
agonistic anti-Fas antibody. Motoneuron sur-
vival was counted 48 hr later and expressed
relative to survival in the presence of NTFs
alone. Results represent meansSD of tripli-
cates from one typical experiment out of
three.
(D) p38 kinase controls nNOS transcription
following Fas activation. Motoneurons in the
presence of NTFs were treated or not with
agonistic anti-Fas antibody (100 ng/ml) in the
presence or absence of SB203580 (5 M). Levels of nNOS were assessed 24 hr later by RT-PCR (increasing number of cycles, 25-30-35
cycles) followed by Southern blotting with specific internal primers. Concentrations of cDNA were normalized using -actin (increasing number
of cycles, 15-20-25 cycles) as standard. As controls, total RNA samples incubated without reverse transcriptase () were submitted to 35
cycles of amplification for nNOS and 25 cycles for -actin. The result presented is representative of three independent experiments.
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Figure 3. ASK-1 and DAXX Are Involved in
Fas-Mediated Motoneuron Death
(A) Freshly purified motoneurons can be effi-
ciently cotransfected. Purified motoneurons
were coelectroporated with expression plas-
mids coding for EGFP and for a HA-tagged
form of ASK1, both under the control of a
CMV promoter. After 24 hr in culture, moto-
neurons were immunostained for HA. The
fraction of EGFP-expressing motoneurons
that were also HA positive was 95%  3%
(mean  range, n  2).
(B) ASK1 is required for Fas-induced moto-
neuron death. Motoneurons were transfected
with an expression vector coding for the
EGFP (pEGFP) in combination with vectors
coding for either wild-type HA-tagged ASK1
(pHA-ASK1), the dominant-negative form of
ASK1 (ASK1-K709R), or an empty vector. Mo-
toneurons from each coelectroporation were
seeded in NTFs, treated (or not) 16 hr later
with sFasL, and the number of EGFP-positive
motoneurons determined 48 hr later. Results
are expressed as the percentage of EGFP-
positive motoneurons surviving in the pres-
ence versus absence of Fas activation.
(C) A dominant-negative form of Daxx saves
motoneurons from the Fas killing effect. Mo-
toneurons were coelectroporated with a plas-
mid expressing EGFP and with plasmids cod-
ing for full-length Daxx (pDaxx-wt) or a dominant-negative form of Daxx comprising its 110 amino acid C-terminal portion (pDaxx-DN).
(D) Daxx is involved in the pathway leading to nNOS upregulation. Same electroporation procedure as in (C). Cells were fixed 24 hr after Fas
activation and immunostained for nNOS. The percentage of nNOS/GFP-positive motoneurons was calculated as the number of motoneurons
strongly stained for nNOS and positive for EGFP divided by the total number of EGFP-positive motoneurons.
(B–D) The results shown are means of three independent experiments. Errors bars indicate SD.
mine whether Daxx was implicated in Fas-induced pathway and examined the downstream effects on the
other pathway.death, motoneurons were electroporated with plasmids
encoding either wild-type Daxx or a dominant-negative We first focused on activation of procaspase-8, which
in motoneurons involves cleavage of the inactive inter-form containing only the C-terminal Fas binding domain
(Daxx-DN) (Yang et al., 1997). Overexpression of wild- mediate form (p43) into active caspase-8 (p18). When
Fas-induced death was blocked using nNOS inhibitors,type Daxx had no effect, whereas overexpression of
Daxx-DN saved motoneurons from Fas-triggered death caspase-8 was activated normally (Figure 4A), sug-
gesting that any effect of the Daxx/p38 pathway on(Figure 3C). To determine if Daxx was acting upstream
of the new NO pathway, we counted the fraction of caspase-8 activation must lie upstream of nNOS. We
therefore inhibited p38 activity using SB203580: cas-motoneurons that showed strong nNOS immunoreactiv-
ity. Daxx-DN completely prevented the Fas-induced in- pase-8 activation was completely prevented (Figure 4B).
These data indicate that p38, one element of the Fas/crease in the number of nNOS-expressing cells (Figure
3D). Moreover, addition of exogenous NO totally abro- NO pathway, can regulate the caspase-8 pathway.
We next examined the release of cytochrome c fromgated the protective effects of ASK1-K709R and Daxx-
DN (data not shown), further confirming that NO produc- mitochondria. To investigate the occurrence of this phe-
nomenon in motoneurons, we followed the subcellulartion is downstream of Daxx, ASK1, and p38 kinase.
distribution of cytochrome c by immunolabeling (Figures
4C and 4D). In the absence of Fas activation, more thanInteractions between Pathways Involving
Daxx/p38 and FADD/Caspase-8 85% of motoneurons showed a granular pattern of cyto-
chrome c immunoreactivity, consistent with a predomi-The existence of the novel Fas/Daxx/Ask/p38/nNOS
pathway led us to examine its functional relationship nantly mitochondrial localization in these conditions.
Following Fas activation, however, 40% of the neuronswith the classical Fas pathway involving FADD-medi-
ated activation of procaspase-8 and cytochrome c re- displayed a more diffuse pattern already after 30 hr
(Figure 4E), consistent with cytochrome c release intolease. The classical FADD/caspase-8 pathway is indeed
involved in Fas-triggered motoneuron death, since cell the cytoplasm. After inhibition of nNOS or inhibition of
caspase-8, the fraction of motoneurons with diffuse cy-death can be prevented by the caspase-8 inhibitor pep-
tide IETD (Raoul et al., 1999) and considerably reduced tochrome c was reduced by only 63% 6% and 60%
10% (means  SD, n  5), respectively. In contrast,by overexpression of a dominant-negative form of FADD
(G. Ugolini, A.O. Hueber et al., personal communication). when using the p38 inhibitor SB203580 the Fas-induced
cytochrome c release was completely blocked (FigureTo begin to understand the relationship between the
two pathways, we therefore blocked elements in one 4E). These observations suggest that p38 not only con-
Neuron
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Figure 4. Synergistic Interactions between
the Nitric Oxide and Caspase-8 Pathways
(A and B) Fas-triggered activation of cas-
pase-8 in motoneurons is controlled by p38.
Motoneurons were treated or not with the in-
dicated reagents (100 ng/ml agonistic anti-
Fas antibody, 100 M L-NAME [A] or 5 M
SB203580 [B]). Inactive and active caspase-
8 were analyzed by immunoblotting with anti-
caspase-8 (p43) or anti-active-caspase-8
(p18) antibodies, respectively. -tubulin im-
munoreactivity was used as a loading control.
Western blots shown are representative of
two independent experiments.
(C and D) Fas activation triggers cytochrome
c release from mitochondria. Motoneurons
were treated with agonistic anti-Fas antibody
(100 ng/ml) and, 30 hr later, immunostained
with anti-cytochrome c antibody. Healthy
MNs show punctate labeling of the mitochon-
dria (C), whereas following Fas activation, a
proportion of the motoneurons show more
diffuse labeling but no pyknotic nucleus (D).
(E) The p38 kinase controls mitochondrial
cytochrome c release. Motoneurons were
treated as in (C) and (D), with or without 5 M
SB203580, 10 M L-VNIO, or 1 M IETD-fmk.
Cytochrome c subcellular localization was
classified as either punctate mitochondrial or
diffuse cytoplasmic. The percentage of moto-
neurons showing diffuse labeling was deter-
mined by direct counting under the fluores-
cence microscope. In the absence of Fas
activation, the inhibitors did not modify the
percentage of motoneurons with diffuse cy-
tochrome c labeling (data not shown).
(F) Synergistic activation of the FADD-cas-
pase-8 and the NO pathway contributes to
Fas-triggered death of motoneurons. Moto-
neurons were treated with the same reagents
as in (C)–(E). At 3 DIV, cell survival was esti-
mated by direct counting of living motoneu-
rons. After counting, motoneurons were
treated again with the same doses of re-
agents, and surviving motoneurons were
counted at 5 DIV. Results show mean values
of three independent experiments, each done
in triplicate. Error bars indicate SD.
trols caspase-8 but also other downstream elements caspase-8 inhibitor was used in combination with an
nNOS inhibitor or with the p38 inhibitor, Fas-triggeredleading to cytochrome c release.
Further evidence for interactions between signaling motoneuron death was completely prevented, sug-
gesting that the FADD-caspase-8 and Daxx/p38 path-pathways is provided by data in Figure 1E and Table 1.
NO alone did not trigger peroxynitrite production or cell ways act synergistically. Taken together, these findings
demonstrate that, in order to trigger motoneuron celldeath. However, when Fas was activated but prevented
from triggering endogenous NO production by addition death, Fas needs to activate, in addition to the classical
FADD-caspase-8 cascade, a novel pathway leadingof L-NAME, exogenous NO led both to peroxynitrite
production and to cell death. Thus, parallel Fas signaling through activation of Daxx, ASK1, and p38 to transcrip-
tional upregulation of the nNOS gene (Figure 9).mechanisms are required for NO to be toxic in normal
motoneurons. These must be either upstream of or inde-
pendent from caspase-8, since IETD did not reduce Fas- Cellular Specificity of the Involvement of Nitric
Oxide in Fas-Triggered Cell Deathinduced peroxynitrite production.
Given these interactions, we looked for survival differ- Since the Daxx/Ask1/p38/nNOS pathway (Figure 9) had
not been previously described, we looked for upregula-ences in conditions in which only one or both pathways
were activated. We analyzed motoneuron survival 4 tion of nNOS in other cell types sensitive to Fas activa-
tion in the absence of transcriptional inhibitors. Whendays after Fas-agonist addition (at 5 DIV), i.e., 2 days
later than in all previous experiments. Under these con- 3T3 Swiss fibroblasts were treated with agonistic anti-
Fas antibody without actinomycin D, about 20% of theditions, single inhibitors had no or only modest effects
on Fas-induced death (Figure 4F). However, when the cells died after 6 hr of treatment (Figure 5A), and as
Motoneuron-Restricted Death Pathway
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Figure 5. Requirement for the Nitric Oxide
Pathway in Fas-Induced Death Is Restricted
to Motoneurons
(A) Fas-induced death of fibroblasts is inde-
pendent of the NO pathway. Swiss 3T3 cells
grown to near confluence were preincubated
with or without 100 M L-NAME, 100 M
D-NAME, 50 M MnTBAP, or 30 M DEVD-
fmk and then treated with agonistic anti-Fas
antibody (100 ng/ml) for 16 hr. Cell survival
was estimated using the MTT assay.
(B) Expression of different NOS isoforms after
Fas activation (agonistic anti-Fas antibody,
100 ng/ml) was assessed using RT-PCR (35
cycles for nNOS, iNOS, and eNOS) followed
by Southern blotting. cDNA levels were nor-
malized using -actin (24 cycles).
(C) Fas-induced death of thymocytes is inde-
pendent of the NO pathway. Freshly-isolated
thymocytes from P5 mice were treated or not
(basal) for 24 hr with agonistic anti-Fas anti-
body (100 ng/ml) in the presence or absence
of 100 M of L-NAME, 100 M of D-NAME,
50 M of MnTBAP, or 30 M of IETD-fmk.
Cell survival was estimated by direct count-
ing, following incubation with the vital dye
calcein AM and ethidium homodimer-1
(EthD-1). Results are expressed as the ratio
of living cells (calcein positive) to the sum of
living cells (calcein positive) and of dying cells
(EthD-1 positive).
(D) Fas activation in thymocytes does not lead
to upregulation of NOS. Primary thymocytes
were incubated or not with agonistic anti-Fas
antibody (100 ng/ml) for 16 hr. Expression
of the three different isoforms of NOS was
analyzed by immunoblotting.
(E) Fas-induced death of mouse cortical neu-
rons is independent of the NO pathway. Pri-
mary cortical neurons from E15.5 cerebral
cortex were maintained in culture for 4 days
before being incubated or not with the indi-
cated reagents (100 ng/ml agonistic anti-Fas
antibody, 100 M L-NAME, 100 M D-NAME,
50 M MnTBAP, or 30 M IETD-fmk). After
24 hr of treatment, cells were fixed and
stained with DAPI; the percentage of cell
death was calculated as the ratio of frag-
mented/condensed nuclei to total nuclei. The
asterisks indicate statistically significant dif-
ferences (p  0.001, n  12) by Student’s t
test.
(F) Fas activation does not modify NOS ex-
pression in cortical neurons. Cortical neurons
cultured for 4 days were treated or not (basal)
with agonistic anti-Fas antibody (100 ng/ml)
for 16 hr. Proteins were extracted, separated
by SDS-PAGE, and immunoblotted with anti-
iNOS, anti- eNOS, or anti-nNOS antibodies
as in (D).
(A, C, and E) Results show typical values of
at least three independent experiments. Error
bars indicate SD.
many as 80% died after 18 hr; as expected, they were sults were obtained using primary cultures of thymo-
cytes (Figures 5C and 5D).saved by the caspase inhibitor DEVD (Figure 5A). How-
ever, no expression of nNOS was detected by RT-PCR This suggested that the NO pathway might be charac-
teristic of neurons. We therefore tested embryonic corti-after 16 hr, and no change in the constitutive levels of
expression of iNOS occurred (Figure 5B). Moreover, the cal neurons, the only other neuronal culture system re-
ported to be sensitive to Fas activation (Cheema et al.,death of 3T3 fibroblasts was not prevented by the NOS
inhibitor L-NAME or the scavenger MnTBAP. Similar re- 1999; Ciesielski-Treska et al., 2001; Morishima et al.,
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2001). Given the relatively small reduction in overall sur- and G37R mutant motoneurons (Figures 7B and 7C).
Concentrations of anti-Fas antibody required to inducevival in these cultures, we counted the percentage of
the half-maximal effect (EC50), calculated from eight dif-neurons showing condensed chromatin (as detected by
ferent experiments, were 11.3  3.4-fold (mean  SEM)DAPI staining). In agreement with published data, there
lower for mutant than for control motoneurons (Figurewas a significant increase in pyknotic nuclei 24 hr after
7F). Thus, mutant SOD1 significantly exacerbates theFas activation (Figure 5E). In surprising contrast with
sensitivity of motoneurons to Fas-mediated death.the situation in motoneuron cultures, however, we could
To further confirm the increased Fas sensitivity ofdetect no increase in levels of nNOS by Western blotting
mutant SOD1 motoneurons, we also assessed the num-(Figure 5F) or RT-PCR (data not shown). This could po-
ber of motoneurons undergoing apoptosis by combinedtentially reflect the low percentage of dying neurons
staining with DAPI and an antibody (CM1) that recog-compared to healthy cells. We therefore asked whether
nizes activated caspase-3 (Srinivasan et al., 1998b), seeinhibitors that completely protect motoneurons affected
Figure 7G. The percentage of CM1-positive motoneu-Fas-triggered death of cortical neurons. Strikingly,
rons with pyknotic nuclei was quantified 25 hr after treat-nNOS or p38 inhibitors had no protective effect (Figure
ment (or not) with an intermediate dose of agonistic5E and data not shown), although Fas-triggered death
anti-Fas antibody (0.5 ng/ml) when the total number ofwas completely prevented by IETD (Figure 5E). Thus,
motoneurons did not yet differ between mutant SOD1motoneurons are currently the only cell type in which
and control cultures. Upon Fas activation, the percent-the NO pathway downstream of Fas is clearly involved
age of motoneurons with activated caspase-3 and nu-in triggering death.
clear condensation increased in G85R motoneuron cul-
tures to a significantly higher extent than in controlMotoneurons from SOD1 Mutant Mice Show
cultures (Figure 7H).Increased Sensitivity to Activation of the Nitric
To exclude the possibility that this simply reflectedOxide Pathway Downstream of Fas
overexpression of human SOD1, we also challengedGiven the existence of a signaling pathway leading spe-
motoneurons from mice overexpressing wild-type SOD1cifically to death of developing motoneurons, we next
with anti-Fas antibody. In striking contrast to the resultsexplored the possibility that this pathway might be in-
with mutant SOD1, overexpression of wt SOD1 con-volved in pathological motoneuron death. As a model
ferred nearly complete protection against Fas-inducedfor familial amyotrophic lateral sclerosis (ALS), we used
death (Figure 7D). Concentrations of anti-Fas antibodytransgenic mice overexpressing the ALS-linked G93A
required to kill motoneurons overexpressing wt SOD1(Gurney et al., 1994), G37R (Wong et al., 1995), or G85R
were at least 1000-fold higher than those required to(Bruijn et al., 1997) SOD1 mutants. We asked whether
trigger death of motoneurons expressing comparablemutant motoneurons might show altered responses to
levels of mutant SOD1 (Figure 7E). Since G37R (BorcheltFas activation.
et al., 1994) and G93A (Rabizadeh et al., 1995) mutantsThe following controls were made for these experi-
are fully catalytically active, the difference between Fasments. (1) Transgenic mice overexpressing G93A, G37R,
susceptibilities of mutant and wt SOD1 motoneurons
G85R, or wild-type (wt) SOD1 were all bred on the same
must reflect the gain of toxic function previously de-
genetic background (C57Bl/6). (2) Mutant and control
duced from genetic analysis of these mice (Bruijn et al.,
motoneurons, when prepared in parallel from individual
1997; Gurney et al., 1994; Wong et al., 1995).
E12.5 embryos, displayed identical yield and viability in We then used pharmacological inhibitors to confirm
the presence of neurotrophic factors (see Experimental that mutant motoneurons were triggered to die by the
Procedures). (3) Expression of the SOD1 transgenes in pathway we had defined using normal motoneurons.
motoneurons cultured for 1 day was verified using an Inhibiting NOS, p38, or caspase-8 completely protected
antibody that recognizes human but not mouse SOD1. mutant SOD1 motoneurons against death triggered by
Strong hSOD1 immunoreactivity was observed in G93A, 0.5 ng/ml or 100 ng/ml anti-Fas (Figure 8A and data not
G37R, and wt SOD1 motoneurons, whereas only low shown). The free radical scavenger MnTBAP provided
signal was detected in G85R motoneurons (Figures partial (75%) protection but to an indistinguishable ex-
6A–6C and data not shown). This is consistent with re- tent in mutant and wild-type cultures (Figure 8A). These
ports showing that levels of the unstable G85R SOD1 results indicate that the same pathway was involved in
protein in spinal cord (Bruijn et al., 1997) are about 10- the Fas-triggered death of mutant motoneurons.
to 20-fold lower than for the G93A (Gurney et al., 1994) A characteristic feature of the motoneuron-specific
and G37R (Wong et al., 1995) proteins. pathway is the induction of nNOS. However, addition
To study the sensitivity of mutant motoneurons to Fas of NO is not itself sufficient to trigger death of normal
activation, anti-Fas antibody was added to cultures after motoneurons (Table 1 and Estevez et al., 1999). We
16 hr at final concentrations between 0.01 and 100 ng/ asked whether this might be different in mutant moto-
ml, and survival was determined 2 days later. Treatment neurons. Mutant and control motoneurons were cul-
of G93A mutant motoneurons with maximal concentra- tured for 16 hr in the presence of neurotrophic factors,
tions of anti-Fas antibody led to death of the same frac- exposed to increasing concentrations (1–20 M) of the
tion of motoneurons (40%–50%) as in control cultures. nitric oxide donor DETANONOate, and counted 1 day
However, the dose-response curve was different. At in- later. In striking contrast with control motoneurons,
termediate levels of Fas activation (0.1–1 ng/ml anti-Fas about 30% of mutant G85R and G93A motoneurons
antibody), the number of surviving G93A motoneurons were triggered to die at 5 M DETANONOate and about
was significantly lower than that of control motoneurons 50% at 20M DETANONOate (Figures 8B and 8C). Thus,
activation of the NO pathway at two different levels(Figure 7A). Similar observations were made using G85R
Motoneuron-Restricted Death Pathway
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Figure 6. Embryonic Motoneurons from Transgenic SOD1 Mice Express Human SOD1 in Culture
(A–F) Double immunolabeling for human SOD1 (A–C) and neurofilament-145 (NF-M) (D–F) in cultured motoneurons from transgenic mice for
SOD1 mutants G93A (A and D), G85R (B and E), or G37R (C and F). Intense hSOD1 labeling was observed in the cytoplasm, axons, and
dendrites of G93A and G37R motoneurons and also of transgenic wt SOD1 motoneurons (data not shown), whereas hSOD1 immunoreactivity
was low in G85R motoneurons and undetectable in control motoneurons (data not shown). Scale bar, 25 m.
results in remarkably exacerbated killing of mutant rons and thymocytes from mice overexpressing mutant
and wild-type SOD1 mice at any concentration (dataSOD1 motoneurons.
not shown). Thus, the exacerbated sensitivity of mutant
motoneurons to Fas-activation and NO strikingly mirrorsSpecificity of Mutant SOD1-Related Toxicity
the cell type specificity of the disease process in vivo.In order to exclude the possibility that cultured SOD1
mutant motoneurons show a generalized increase in
susceptibility to death-inducing agents, we explored Discussion
their responses to trophic deprivation and excitotoxicity.
When seeded in the absence of neurotrophic factors, Our main hypothesis in this work was that death path-
ways restricted to specific classes of neurons couldabout 75% of control motoneurons died by 3 DIV. Under
these conditions, cell death occurred to an identical potentially provide a basis for better understanding the
precise control of developmental neuronal death andextent in parallel cultures of G37R, G85R, and wt SOD1
motoneurons (Figure 8D). Next, since excessive stimula- the selectivity of neuronal loss in patients with neurode-
generative diseases. By studying the signaling mecha-tion of glutamate receptors is potentially involved in ALS
pathogenesis (Rothstein, 1995), we triggered excitotoxic nisms used by the Fas receptor in primary motoneurons,
we have defined a novel pathway whose key step is thedeath of motoneurons by adding the AMPA receptor
agonist domoic acid to cultures maintained for 5 DIV transcriptional regulation of nNOS downstream of p38
kinase. Strikingly, we could not find evidence for thiswith neurotrophic factors (Cisterni et al., 2001). Domoic
acid induced a dose-dependent death of motoneurons pathway in other cell types. This led us to ask whether
such a mechanism might be involved in the selectivethat was indistinguishable between control, G85R,
G93A, and wt SOD1 cultures (Figure 8E, data not shown motoneuron degeneration observed in mice that overex-
press ALS-linked mutant forms of SOD1. Motoneuronsfor G93A).
In vivo pathology in mutant SOD1 mice is relatively purified from these mice show a specifically exacer-
bated response to exogenous Fas agonists and NO.selective for motoneurons. In order to confirm that in-
creased Fas and NO sensitivity in vitro was similarly Thus, although involvement of the NO pathway in vivo
remains to be confirmed, our findings provide a rationalecell type specific, we prepared cultures from different
tissues of control, mutant, and wt SOD1 mice (Table 2). for the selective vulnerability of motoneurons that is
characteristic of this model of ALS.Thymocytes and cortical neurons, both of which are Fas
sensitive (Cheema et al., 1999; Ogasawara et al., 1995), Cell type-dependent differences in Fas signaling path-
ways have previously been reported, depending on thedid not show increased Fas sensitivity when prepared
from control, G85R, G93A, or wt SOD1 mice (Table 2 intensity of caspase-8 activation and the degree of
involvement of the mitochondrion (Scaffidi et al., 1998,and data not shown). DRG sensory neurons showed
very low Fas sensitivity with no statistically significant 1999). In Type I cells, activation of caspase-8 at the
DISC is directly followed by caspase-3 activation inde-difference between mutants and controls. Last, cerebel-
lar granule neurons and astrocytes, which are normally pendently of mitochondrial function. In Type II cells,
caspase-8-dependent death can be blocked by overex-not Fas sensitive, did not become Fas sensitive in the
mutants. The NO susceptibility of the mutant cells was pression of antiapoptotic members of the Bcl-2 family,
reflecting in some cases a requirement for cleavage ofsimilarly cell type specific: no difference in the response
to DETANONOate was observed between cortical neu- the BH3-only family member Bid (Li et al., 1998; Luo et
Neuron
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Figure 7. Mutant SOD1 Expression in Embry-
onic Motoneurons Causes Increased Sensi-
tivity to Fas Activation
(A–F) Motoneurons from transgenic mice for
mutant SOD G93A (A), G85R (B), G37R (C)
display increased sensitivity to Fas-triggered
death, whereas wt SOD1 motoneurons (D) are
almost completely protected. Varying con-
centrations of an agonistic anti-Fas antibody
were added to motoneurons from transgenic
or control mice and survival assessed at 3
DIV and expressed as the percentage of the
number of motoneurons surviving at the
same time without anti-Fas antibody addi-
tion. Each figure is representative of one out
of two to three experiments performed in qua-
druplicate for each condition. Error bars rep-
resent SEM. Asterisks indicate the level of
statistical significance for the difference be-
tween mutant and control motoneurons at a
given concentration of anti-Fas as tested by
Student’s t test, two-tailed, unpaired: *p 
0.05, **p  0.01, ***p  0.001. No asterisk, no
statistical difference. Note that all cultures
were performed in the presence of optimal
concentrations of neurotrophic factors.
(E) Cumulative data for the Fas sensitivity of
mutant SOD1 motoneurons in comparison to
motoneurons overexpressing wild-type SOD1.
(F) Mean concentrations of anti-Fas antibody
required to trigger death of 50% of Fas-sensi-
tive motoneurons (EC50, in ng/ml) were signifi-
cantly lower (p  0.025 by Student’s t test,
two-tailed, paired) in G93A, G85R, and G37R
cultures than in parallel control cultures. His-
tograms and error bars represent means 
SEM.
(G and H) Increased apoptosis in G85R moto-
neuron cultures following Fas activation. Cul-
tures were treated (or not) with agonistic anti-
Fas antibody (0.5 ng/ml) for 25 hr and stained
with DAPI and an antibody against activated
caspase-3 (CM-1, in red). (G) Apoptotic moto-
neurons with strong diffuse CM-1 labeling,
neurite breakdown, and nuclear condensa-
tion (red arrow) could be easily distinguished
from healthy motoneurons displaying weak
CM1 labeling and normal chromatin structure
(white arrows). Scale bar, 25 m. (H) The frac-
tion of CM1-positive pyknotic motoneurons
increased in G85R cultures from 7.7% 1.3%
(mean  SEM) to 21.9%  0.7% upon anti
Fas treatment, i.e., to a significantly higher
extent than in control cultures (from 8.9% 
1.8% to 16.4%  0.4%; n  3 per condition,
**p  0.006 by Student’s t test, two-tailed,
unpaired).
al., 1998). In these cells, caspase-3 is activated as a tempting to speculate that during evolution, the tran-
scriptionally regulated NO pathway has been graftedresult of cytochrome c release from mitochondria. Pri-
mary motoneurons correspond to neither Type I nor onto the classical cascade as a means of providing finer
control of the death of these essentially irreplaceableType II cells, and we propose to classify them as Type
III cells. In these, caspase-8 activation is not sufficiently neurons. Other members of the same receptor family
as Fas, such as TNFR1 and p75NTR, can also triggerintense to alone cause rapid cell death and requires
coactivation of p38 and transcription of nNOS. It is neuronal death (Barker et al., 2001; Frade and Barde,
Motoneuron-Restricted Death Pathway
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Figure 8. Specific Killing of Mutant SOD1
Motoneurons by Nitric Oxide
(A) Fas-induced death of both control and
mutant G85R and G93A motoneurons was
significantly inhibited by the reactive oxygen
radical scavenger MnTBAP (50M) and com-
pletely blocked by the general NOS inhibitor
L-NAME (100 M), the neuronal NOS inhibitor
L-VNIO (10 M), and the caspase-8 inhibi-
tor IETD-fmk (1 M).
(B and C) Mutant motoneurons are killed by
NO. Mutant G93A (B) or G85R (C) motoneu-
rons were exposed to DETANONOate (1–20
M; plotted linearly) 16 hr after seeding and
survival quantified at 2 DIV. Asterisks indicate
level of statistical significance as assessed
by Student’s t test, two-tailed, unpaired: *p
0.05, **p  0.01, ***p  0.001. No asterisk, no
statistical difference.
(D) Trophic factor deprivation-induced death
is similar for control, G37R, G85R, and wt
SOD1 motoneurons. Cell survival in the pres-
ence of trophic factors at 3 DIV did not differ
between the indicated genotypes and was
set to 100%; only the histogram for control
motoneurons is shown.
(E) Excitotoxic death of motoneurons is simi-
lar for control, G85R, and wt SOD1 motoneu-
rons. Cells were treated at 5 DIV with domoic
acid (1010 to 106 M), and survival was quan-
tified at 7 DIV. In these experiments, domoic
acid-induced cell death was completely pre-
vented by CNQX or NBQX, two different com-
petitive receptor antagonists (data not shown).
(A–E) Data are each representative of at least
two independent experiments performed in
triplicate or quadruplicate. Error bars repre-
sent SD (A) or SEM (B–E).
1998; Raoul et al., 2000; Robertson et al., 2001; Terrado nase family activated downstream of ASK1 is p38 ki-
nase, which has been implicated in many neuronal cellet al., 2000). It will be interesting to see whether these
receptors, too, have developed neuron-specific signal- death mechanisms (Harper and LoGrasso, 2001; Mielke
and Herdegen, 2000). Although JNK is active in moto-ing mechanisms.
Other elements of the NO pathway defined here had neurons (Borasio et al., 1998; Maroney et al., 1998),
levels of phospho-JNK were not modulated by Fas, andbeen reported in the literature, but their involvement in
physiologically relevant Fas signaling was in some cases Fas-triggered death was not prevented by JNK1 inhibi-
tor. In contrast, there was a reproducible though modestcontroversial. Daxx was first identified as a Fas inter-
actor that could activate JNK and apoptosis in HeLa and increase in relative levels of phospho-p38 following Fas
activation, and nNOS upregulation, cytochrome c re-embryonic kidney cell lines (Yang et al., 1997). Although
Daxx is expressed in the brain (Yang et al., 1997), Daxx lease, and Fas-triggered death were all blocked by low
concentrations of p38 inhibitor SB203580. Activation ofknockout mice die before E9.5, precluding analysis of
a role in neuronal death (Michaelson et al., 1999). The ASK1 often leads to activation of both JNK and p38
(Tobiume et al., 2001), but some reports indicate thatprimary target of Daxx is the MAP3K ASK1 (Chang et
al., 1998). ASK1 is essential for Fas-induced apoptosis they can be activated independently, depending on the
specific MAP2K activated by ASK-1 (for reviews, seein several cell lines (Chang et al., 1998) and for death of
sympathetic neurons deprived of NGF (Kanamoto et al., Mielke and Herdegen, 2000; Ono and Han, 2000). p38
can activate numerous substrates (for review, Harper2000). In motoneurons, the key member of the SAP ki-
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Table 2. Fas Sensitivity of Different Cell Types from Transgenic SOD1 and Control Mice
Cell Survival (%  SEM)
Cell Type anti-Fas (ng/ml) Control G85R SOD1 wt SOD1
Thymocytes 0.1 87  1.4 90  0.6 91  1
1 83  1.4 90  0.6 89  1
10 66  1.2 83  1.4 83  2.3
100 63  1.4 77  1.5 73  2.6
1000 53  1.2 76  2.3 69  3.5
DRG neurons 1 108.4  4.5 100  4.3
10 107.9  1.1 93.3  6.1
100 91.5  2.0 87.6  2.1
Cerebellar granule neurons 100 96.5  1.1 101.7  1.7
1000 97.2  2.6 96.4  1.7
Astrocytes 100 104.8  2.6 98.7  1.2
1000 103.6  1.2 95.2  1.5
Cell Death (%  SEM)
Cell Type anti-Fas (ng/ml) Control G85R SOD1 wt SOD1
Cortical neurons 0.5 9.8  1.2 9.8  1.2 9.6  0.9
100 17.6  0.6 16.3  1.2 14.9  0.6
After treatment with anti-Fas antibody, cultures of different cell types from transgenic SOD1 mice did not show greater cell death than control
cultures. For thymocytes, cell viability was estimated using a live/dead assay; for DRG neurons, cerebellar granule neurons, and astrocytes,
survival was assessed using the MTT assay; for cortical neurons, percentage of cell death was determined after DAPI staining.
and LoGrasso, 2001), including transcription factors of the nNOS gene did not prolong their survival (Facchi-
netti et al., 1999). Nevertheless, nNOS mutant mice aresuch as ATF-2 or CREB (Tan et al., 1996). Interestingly,
transcription of the nNOS gene is CREB dependent in not complete nulls and still produce  and 	 isoforms
of nNOS, leading to reduced but still significant overallother systems (Sasaki et al., 2000).
Our demonstration of a motoneuron-specific death levels of nNOS catalytic activity (Facchinetti et al., 1999).
Strikingly, specific increases in the same nNOS isoformspathway raised the question of its possible involvement
in a condition of pathological motoneuron death. Using have been reported in spinal cords from sporadic ALS
patients (Catania et al., 2001). Thus, published resultsmotoneurons isolated from three different transgenic
mouse lines harboring ALS-linked SOD1 mutations, we do not exclude the involvement of NO, which is sug-
gested by our in vitro results and the pharmacologicalindeed demonstrated enhanced susceptibility to activa-
tion of the Fas pathway leading to activation of cas- effects of AR-R 17,477 in vivo.
Neurodegeneration in transgenic SOD1 mice in vivopase-8, caspase-3, and ultimately death. These abnor-
malities preceded by about 2 weeks the earliest reported has only been observed when mutant SOD1 was ex-
pressed ubiquitously under the control of its own pro-motoneuron loss in mutant SOD1 spinal cord (Lowry et
al., 2001) and by about 2 months the occurrence of other moter (Bruijn et al., 1997; Gurney et al., 1994; Wong et
al., 1995); specific overexpression in neurons (Lino ethistopathological and electrophysiological changes
(Frey et al., 2000; Kennel et al., 1996). Our findings do al., 2002; Pramatarova et al., 2001) or in astrocytes (Gong
et al., 2000) did not lead to pathology. Our in vitro resultsnot necessarily mean that mutant SOD1 motoneurons
are already affected during embryonic development, indicate that mutant SOD1-related motoneuron death
proceeds cell-autonomously but can be triggered bysince the concentrations of death inducers used here
may be higher than those encountered in vivo, and levels diffusible factors such as Fas-agonists and NO. These
factors might have different sources (Figure 9). Activatedof intrinsic signaling intermediates may be upregulated
as a result of culturing. microglia in culture have been shown to produce NO
and FasL (Ciesielski-Treska et al., 2001, and referencesOur results suggest that mutant SOD1 toxicity affects
Fas-triggered death at a level downstream of nNOS but therein). Astrocytes have been shown to contain in-
creased levels of NOS in mutant SOD1 mice and alsoupstream of the late-stage apoptotic cascade: mutant
motoneurons displayed increased susceptibility to ex- in ALS patients (Almer et al., 1999; Anneser et al., 2001;
Catania et al., 2001). Sera have been reported to containogenous NO but normal cell death responses to trophic
deprivation and excitotoxicity. This suggests a key role high levels of agonistic Fas antibodies in some sporadic
ALS patients (Yi et al., 2000). This opens the possibilityfor NO in triggering mutant motoneuron death. The
nNOS inhibitor AR-R 17,477, when orally administered that NO, Fas agonists, or other diffusible factors, pro-
duced outside motoneurons, might trigger or amplifyfrom day 30, has been shown to significantly prolong
the life span of G93A mutant mice (Facchinetti et al., neurodegeneration.
Finally, it will be of obvious interest to examine the1999). Other inhibitors however were ineffective (Facchi-
netti et al., 1999; Upton-Rice et al., 1999), maybe due to specific role of the Fas pathway in different experimental
models of in vivo motoneuron degeneration. Our prelimi-low bioavailability in vivo. Moreover, crossing of mutant
SOD1 mice with mice carrying a loss-of-function allele nary results show that traumatic neurodegeneration is
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mice were obtained from Iffacredo (L’Arbresle, France). Transgenic
mice for mutant G85R, G37R, or wild-type human SOD1 were from
Ludwig Institute (San Diego); transgenic mice for G93A human SOD1
were obtained from Transgenic Alliance (L’Arbresle, France). Mutant
G93A (line G1H [Gurney et al., 1994]), G37R SOD1 mice (line 42
[Wong et al., 1995]), and transgenic mice for wild-type human SOD1
(line 76 [Wong et al., 1995]) were maintained as hemizygotes by
crossing transgenic males with nontransgenic females of the same
genetic C57BL/6 background. Offspring were genotyped by sepa-




exon 5 (primers 5
-TGTTGGGAGGAGGTAGTGATTA and 5
-AGCA
GAGTTGTGTTAGTTTTAG). In each PCR reaction, the mouse globin
gene was amplified with primers 5
-GATCATGACCGCCGTAGG and
5
-CATGAACTTGTCCCAGGCTT. For G93A, G37R, and wt SOD1
embryos, transgenic and control embryos were from the same lit-
ters. During PCR genotyping of embryonic tail DNAs (3–4 hr), em-
bryos were kept at 4C in Hibernate E medium (Gibco). Mutant G85R
mice (line 148 [Bruijn et al., 1997]) were maintained as homozygotes.
Hemizygous G85R embryos were obtained from crosses between
male G85R mice and female C57BL/6 mice, and age-matched
C57BL/6 embryos were used as controls.
Reagents
Hamster anti-mouse Fas antibody (JO2 clone) and mouse mono-
clonal anti-cytochrome c (6H2.B4 clone) were purchased from Phar-
mingen International, San Diego, CA. z-DEVD-fmk, z-IETD-fmk,Figure 9. A Cell-Autonomous Death Pathway that Can Be Triggered






 (21H,2H-porphine-5,10,15,20-by Environmental Stimuli
tetrayl) tetrakis (benzoic acid), referred to as MnTBAP, and the pyri-The presence of mutant SOD1 sensitizes motoneurons downstream
dinyl imidazole p38 inhibitor SB203580 were purchased from Calbio-of NO. Astrocytes and microglia represent potential sources of cell
chem (La Jolla, CA). Rabbit polyclonal antibodies against nNOSdeath triggers.
(lot# 14552a) and DETANONOate were purchased from Cayman
Chemical, Ann Arbor, MI. Production and characterization of affinity-
purified rabbit polyclonal antibodies to nitrotyrosine were described
partly prevented in mice mutant for Fas and its signaling elsewhere (Beckman et al., 1994). Anti-active p38 and anti-active
components (G. Ugolini et al., personal communication). JNK rabbit polyclonal antibodies were purchased from Promega;
anti-p38 and anti-JNK rabbit polyclonal antibodies were from NewThe next step will be to cross mutant SOD1 mice to lines
England Biolabs Inc. Rabbit polyclonal antibodies against induciblein which Fas activity is attenuated; similar experiments
NOS (lot# L03202), endothelial NOS (lot# 04766), soluble Fas-Ligandcould be performed using mouse models for spinal mus-
(sFasL), enhancer antibodies for tagged sFasL, rhAPO-1/Fas:Fc-
cular atrophy (SMA). The standard Fas knockout mice IgG (Fas-Fc), LG-Nitro-L-arginine-methyl ester.HCl (L-NAME), LG-Nitro-
may not be appropriate for these crosses, as they still D-arginine-methyl ester.HCl (D-NAME), [N5-[Imino(propylamino)
express high levels of a truncated Fas protein (Adachi methyl]-L-ornithine; N-Propyl-L-arginine] (NPLA), [N5-(1-Imino-3-
butenyl)-L-ornithine; Vinyl-L-NIO] (L-VNIO), [1-(2-Trifluoromethyl-et al., 1995), which may have kept some of its signaling
phenyl)imidazole] (TRIM) were from Alexis Corp., Switzerland. Poly-capacity for this novel pathway, in particular the interac-
clonal antibodies against hemagglutin (HA)-tag were from Clontechtion with Daxx (Yang et al., 1997). It will also be of interest
Laboratories, Inc. Rabbit polyclonal antibodies against Fas (M-20)
to test the therapeutic efficacy of p38 inhibitors in ALS and Fas-Ligand (N-20) were from Santa Cruz Biotechnology; anti-
and SMA models. NF-M (Ab1987) from Chemicon; mouse monoclonal anti-SOD1
Precise control of neuronal cell death is a prerequisite (clone SD-G6) anti-NF 160 (clone NN18) were from Sigma.
for normal brain development, and selective loss of spe-
Expression Constructscific neuronal populations is one of the key common
The cDNA coding for full-length mouse Daxx, referred to as Daxx-features of neurodegenerative diseases such as Alzhei-
wt, or for the C-Terminal 110 amino acids of Daxx, referred to asmer’s, Parkinson’s, or Huntington’s disease. In most
Daxx-DN (Yang et al., 1997), were cloned into pcDNA3 (Invitrogen).
familial forms of these diseases, mutant proteins are HA-tagged human ASK1 (HA-ASK1-wt) and the catalytically inactive
expressed in unaffected brain regions and thus are un- mutant ASK1-K709R (Kanamoto et al., 2000) were also cloned in
likely to themselves restrict the site of pathology. The pcDNA3.
model we have illustrated here for the specific case of
motoneurons and mouse models of ALS may be more Motoneuron Purification and Culture
Motoneuron cultures were prepared from E12.5 mice spinal cordsgenerally applicable: neuronal class-specific pathways
essentially as described previously (Arce et al., 1999; Henderson etfor degeneration or death, potentially sensitized by ge-
al., 1995). Motoneurons were plated in the presence of a cocktailnetic or environmental factors. If such pathways are
of neurotrophic factors (referred as “NTFs”: 1 ng/ml BDNF, 100 pg/
indeed implicated in human pathologies, they may pro- ml GDNF, 10 ng/ml CNTF) added at the time of cell seeding. After 16
vide important targets for selective therapeutic inter- hr in culture, they were treated by addition of the different reagents
diluted in Neurobasal medium. Unless otherwise indicated, moto-vention.
neurons were then incubated at 37C for 48 hr, and living cells were
counted under phase-contrast. Since the fraction of motoneuronsExperimental Procedures
triggered to die was never greater than 50%, all survival graphs
were plotted with 40% of optimal survival as the lowest value shown.Animals
Mice were kept in an inverted dark/light cycle (dark 11 am to 9 pm) To compare the yield of motoneurons from transgenic SOD1 and
control mice, motoneurons were purified and the number of cellsand positive vaginal plugs at 9 hr am recorded as E0.5. Normal CD1
Neuron
1080
in suspension counted. In both mutants and controls, the yield of Other Cell Cultures and Apoptosis Assays
Swiss 3T3 cells were maintained in DMEM medium (Gibco BRL)purified motoneurons per spinal cord was equivalent. After seeding,
motoneuron survival in the absence of Fas activation remained con- supplemented with 10% fetal-calf serum and 1% penicillin-strepto-
mycin. Cells were plated on 24-well plates and cultured to nearstant between 1 and 3 DIV. In these conditions, no significant survival
differences at 3 DIV were found in a retrospective analysis of 36 confluency prior to treatment with IETD-fmk, L-NAME, or MnTBAP,
which were added to the culture medium 2 hr prior to addition ofparallel motoneuron cultures from controls (set to 100%) and mu-
tants: G93A (107%  7%, mean  SEM, n  16), G37R (93%  agonistic anti-Fas antibody (JO2) at 100 ng/ml. Cell survival was
measured using the MTT assay (Manthorpe et al., 1986).11%, n  4), G85R (97%  17%, n  9), and wt SOD1 (109% 
7%, n  7). Thus, the purification and culture procedures employed Thymocytes were prepared from P5 mouse thymuses as de-
scribed (Fisher et al., 1996), with minor modifications. Cells weredid not generate bias by selecting quantitatively different subpopu-
lations of mutant and control motoneurons. cultured for 3 hr and treated with the indicated reagents. Cell viability
was estimated 24 hr later using Live/Dead Viability/Cytotoxicity KitFor excitotoxicity experiments, motoneurons were cultured for 5
DIV in the continued presence of NTFs, medium was changed, and (Molecular Probes). The percentage of viable thymocytes was cal-
culated as follows: [number calcein AM positive cells/(numbercells were treated with domoic acid and/or other indicated reagents
(Cisterni et al., 2001). Cell viability was quantified at 7 DIV. For NO- EthD-1  calcein AM positive cells)]  100.
Primary cortical neurons were cultured from E15 mouse embryos.induced death, motoneurons were cultured for 16 hr in the presence
of NTFs alone and then treated with different concentrations of Cerebral cortices were dissociated in HBSS, 0.4% BSA, 100 g of
DNase after digestion in 0.125% Trypsin/HBSS. Cells were thenDETANONOate.
centrifuged on a BSA cushion at 1500 rpm for 5 min and plated on
polyornithine/laminine-treated wells at the density of 150,000 cells/
Statistical Methods cm2. Cortical neuron cultures were maintained for 4 days in DMEM
The number of surviving or immunoreactive motoneurons in each with 2% B27 supplement (Life Technologies) and 1 mM sodium
condition was expressed as a percentage of the number of moto- pyruvate at 37C, 5% CO2. Medium was changed and cells were
neurons surviving in the presence of trophic factors alone; triplicate treated with indicated reagents for 24 hr. Neurons were fixed and
or quadruplicate dishes were used for each condition. If not other- nuclei were stained with DAPI. Cell death was determined by count-
wise indicated, differences between treatments or genotypes were ing cells with condensed or fragmented nuclei in four to seven fields
analyzed for their statistical significance by student’s t test, two- (400–600 cells) per well in a blinded manner. Data are expressed as
tailed, unpaired. the percentage of apoptotic cells among the total cells counted. For
NO-induced death of cortical neurons, cells isolated from indicated
strain were cultured for 24 hr and treated for 48 hr with increasing
Electroporation of Motoneurons concentrations of DETANONOate. Cell survival was measured using
Cells dissociated from E12.5 mice ventral spinal cord were centri- MTT assay.
fuged over a 5% (v/v) Optiprep cushion at 2000 rpm for 15 min. Dorsal root ganglion neuronal cultures (DRG) were obtained from
Cells at the interface were collected and washed on a BSA cushion E16-17 mouse embryos following the procedure described (Varon
at 1500 rpm for 5 min. Pellets were resuspended in electroporation et al., 1981). Agonistic anti-Fas antibodies were added at their final
buffer (125 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 10 mM glucose, 20 concentrations immediately after seeding. Cell survival was esti-
mM HEPES [pH 7.4]) at a density of 50,000 cells per 100 l. Five mated after 48 hr, by counting MTT-positive neurons. Astrocytes
micrograms of pEGFP-N1 (Clontech Laboratories, Inc.) and the were obtained from E16 mouse embryos, as described (Pettmann
same molar amount of the vector of interest were added to the 100 et al., 1991) with slight modifications. Cells were treated 24 hr after
l cell suspension. Motoneurons were incubated at room tempera- subculture with agonistic anti-Fas antibody and their survival esti-
ture for 15 min, transferred to a 4 mm gap cuvette (Eppendorf), mated after 48 hr using the MTT assay.
and electroporated using Electro square porator BTX-ECM830,
Genetronics Inc. Electroporation conditions were three pulses of 5
RT-PCR Analysis of NOS Expression
ms at 200V with intervals of 1 s. Culture medium was added rapidly
For each condition, about 60–80,000 purified motoneurons were
to dilute the cells after electroporation, and cells were plated in four-
seeded in two 35 mm diameter dishes. For Swiss 3T3 fibroblasts,
well plates.
cells were grown to near confluency in 6 cm diameter dishes. At
the indicated time and treatment, total RNA was extracted using
Trizol reagent (Life Technologies) according to the manufacturer’sImmunocytochemistry
instructions. The retrotranscription step was performed using Su-Motoneurons seeded on glass coverslips were treated or not as
perscript II (Gibco BRL) reverse transcriptase and random hexamerindicated and fixed in 3.7% (v/v) formaldehyde, washed in PBS
primers. Normalization of cDNA levels was done by PCR on a Perkin-containing 50 mM L-Lysine, and blocked for 1 hr with 5% (v/v)
Elmer Thermal Cycler using as reference primers for -actin (nucleo-donkey serum, 4% BSA, 0.1% (v/v) Triton X-100 in PBS. Cells were
tides 304 to 327, 5
-TTGTAACCAACTGGGACGATATGG and nucleo-incubated with the primary antibodies (rabbit polyclonal anti-nNOS
tides 1044 to 1067, 5
-GATCTTGATCTTCATGGTGCTAGG (GenBankdiluted 200-fold, polyclonal anti-HA 500-fold, anti-SOD1 (SD-G6)
accession number GI49865). PCR primers for mouse nNOS were600-fold, anti-NF-M (Ab1987) 500-fold, anti-activated Caspase-3
nucleotides 1766 to 1786, 5
-CCTGGGGCTCAAATGGTATGG, and(CM1) 5000-fold) in the blocking solution, followed by fluorochrome-
nucleotides 2633 to 2653, 5
-GAATAGGAGGAGACGCTGTTG (Gen-conjugated secondary antibodies. Immunofluorescence staining of
Bank accession number D14552). Primers for mouse iNOS werenitrotyrosine and analysis of fluorescence intensity was done as
nucleotides 2201 to 2221, 5
-CAACAGGAGAAGGGGACGAAC, anddescribed (Estevez et al., 1998a) on 150–300 randomly chosen cells
nucleotides 2791 to 2811, 5
-TCTCTGCCTATCCGTCTCGTC (Gen-per culture condition.
Bank accession number M87039). Primers for eNOS were nucleo-
tides 1549 to 1569, 5
-GAAGCGTGTGAAGGCAACCAT, and nucleo-
tides 2319 to 2335, 5
-TTGTGGCTCGGGTGGATTTGC (GenBankMonitoring of Cytochrome c Release
accession number U53142). Internal oligonucleotide probes usedMotoneurons grown for 16 hr on glass coverslips were treated with
for Southern blots were 5
-TGACCATCGTTGACCACCACT forthe indicated reagents. After 30 hr of treatment, cells were stained
nNOS, 5
-TGAAAAGTCCAGCCGCACCAC for iNOS, 5
-AGAAGTGGusing the mouse monoclonal anti-cytochrome c (6H2.B4) at 1 g/
GGGTATGCTCGGG for eNOS. Membranes were washed in decreas-ml as the primary antibody and streptavidin-conjugated Cy3 anti-
ing concentrations of SSC and then exposed for autoradiography.mouse as a secondary antibody. The diffuse labeling of cytochrome
c was estimated under a fluorescence microscope and confirmed
by confocal analysis. The percentage of cells presenting a diffuse Western Blot Analyses
Purified motoneurons were seeded at a density of 150,000 cells perlabeling over the total number of labeled cells was estimated on
two diameters of the well, representing about 50 different fields per 6 cm dish. Motoneurons were cultured in the presence of NTFs for
16 hr. They were treated or not with either 100 ng/ml of sFasL culture condition.
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Enhancer (1 g/ml) for 120 min (p38/JNKs) or 100 ng/ml of agonistic Bonny, C., Oberson, A., Negri, S., Sauser, C., and Schorderet, D.F.
(2001). Cell-permeable peptide inhibitors of JNK: novel blockers ofanti-Fas antibody for 18 hr in the presence or in the absence of 5
M SB203580 or 100 M L-NAME. Cell extract proteins were sepa- beta-cell death. Diabetes 50, 77–82.
rated on 15% SDS-PAGE and Western blotting performed using Borasio, G.D., Horstmann, S., Anneser, J.M., Neff, N.T., and Glicks-
antibodies against active p38, phospho-JNKs, p38, JNKs, caspase- man, M.A. (1998). CEP-1347/KT7515, a JNK pathway inhibitor, sup-
8 p18 (SK440) (Matsushita et al., 2000), or caspase-8 (Srinivasan et ports the in vitro survival of chick embryonic neurons. Neuroreport
al., 1998a) diluted 1000-fold. For subsequent immunodetection of 9, 1435–1439.
NF-M or -tubulin, membranes were first stripped of bound antibod-
Borchelt, D.R., Lee, M.K., Slunt, H.S., Guarnieri, M., Xu, Z.S., Wong,
ies. The relative intensity of phosphorylated p38 and JNKs was
P.C., Brown, R.H., Jr., Price, D.L., Sisodia, S.S., and Cleveland, D.W.
determined using an AGFA densitometer, and data were analyzed
(1994). Superoxide dismutase 1 with mutations linked to familial
using the NIH image 1.62 software. For nNOS protein detection,
amyotrophic lateral sclerosis possesses significant activity. Proc.
thymocytes and cortical neurons were seeded at a density of
Natl. Acad. Sci. USA 91, 8292–8296.
150,000 cells per cm2 in 6 cm Petri dishes, treated or not with
Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A.,agonistic anti-Fas antibody, and lysed at the indicated time. Sample
Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price,proteins were resolved by 6% SDS-PAGE and submitted to Western
D.L., and Cleveland, D.W. (1997). ALS-linked SOD1 mutant G85Rblotting using anti-NOS following manufacturer’s instructions.
mediates damage to astrocytes and promotes rapidly progressive
disease with SOD1-containing inclusions. Neuron 18, 327–338.Acknowledgments
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